2023 ´ëÇѽÉÀåÇÐȸ ½ÉÀåÁ¾¾çÇבּ¸È¸ ÇÏ°è ½ÉÆ÷Áö¿ò : 2023-07-01
±³À°ÀÏÀÚ : 2023-07-01
±³À°Àå¼Ò : The-K È£ÅÚ ¼¿ï, º»°ü °Å¹®°íȦ (3Ãþ)
±³À°ÁÖÁ¦ : 2023 ´ëÇѽÉÀåÇÐȸ ½ÉÀåÁ¾¾çÇבּ¸È¸ ÇÏ°è ½ÉÆ÷Áö¿ò
ÁÖÃÖ±â°ü : ´ëÇѽÉÀåÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ½ÉÀå-Á¾¾çÇÐ ¿¬±¸È¸
´ã´çÀÚ : Â÷¿¬Á¤
¿¬¶ôó : 02-6002-1394
À̸ÞÀÏ : cardiooncology@naver.com
±³À°Á¾·ù : ³»°ú, ¿Ü°ú, ¹æ»ç¼±Á¾¾çÇаú
Âü¼®¿¹»óÀÎ : 50¸í
Èñ¸ÁÆòÁ¡ : 3Á¡
Áö¿ª : ¼¿ïƯº°½Ã
±³À°½Ã°£ : 4 ½Ã°£ 0ºÐ
¼¼ºÎ¼ö°·á : 20,000¿ø
ºñ°í Àü¹®ÀÇ »çÀüµî·Ï: 1¸¸¿ø, ÇöÀåµî·Ï: 2¸¸¿ø
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 07¿ù 01ÀÏ ´õÄÉÀÌÈ£ÅÚ °Å¹®°íȦ 09:00~09:15 Update of Guidelines on Cardio-oncology: Trends and Essentials (ÃÑ·ÐÀûÀÎ °ÀÇ) Á¤¹ÌÇâ(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 07¿ù 01ÀÏ ´õÄÉÀÌÈ£ÅÚ °Å¹®°íȦ 09:15~09:30 Cardiotoxicity of Anthracycline and HER2-targeted therapies ±è¹Ì³ª(°í·ÁÀÇ´ë)
±³À°½Ã°£ 07¿ù 01ÀÏ ´õÄÉÀÌÈ£ÅÚ °Å¹®°íȦ 09:30~09:45 Cardiorenal Toxicity of VEGF inhibitors ¹ÚÀαÙ(¿ï»êÀÇ´ë)
±³À°½Ã°£ 07¿ù 01ÀÏ ´õÄÉÀÌÈ£ÅÚ °Å¹®°íȦ 09:45~10:00 Cardiotoxicity of TKI targeting BCR-ABL À̼ºÀº(°¡Å縯ÀÇ´ë)
Åä·Ð 07¿ù 01ÀÏ ´õÄÉÀÌÈ£ÅÚ °Å¹®°íȦ 10:00~10:20 Åä·Ð ÃÖÇýÁø,±è´Ù·¡,¼Áö¿ø,ÀÌÇý¿ø,À̼±È(¿¬¼¼ÀÇ´ë,¼º±Õ°üÀÇ´ë,¿¬¼¼ÀÇ´ë,±¹¸³¾Ï¼¾ÅÍ,°è¸íÀÇ´ë)
ÈÞ½Ä 07¿ù 01ÀÏ 10:20~10:40 ÈÞ½Ä ()
±³À°½Ã°£ 07¿ù 01ÀÏ ´õÄÉÀÌÈ£ÅÚ °Å¹®°íȦ 10:40~10:55 ¾ÏȯÀÚ Ä¡·á°úÁ¤¿¡¼ ³ªÅ¸³ª´Â ½ÉÀå¹®Á¦ Questions: Oncologists ÀÌÀ±±Ô(¼º±Õ°üÀÇ´ë)
±³À°½Ã°£ 07¿ù 01ÀÏ ´õÄÉÀÌÈ£ÅÚ °Å¹®°íȦ 10:55~11:10 ¾ÏȯÀÚ Ä¡·á½Ã ÈçÈ÷ Á¢ÇÏ´Â ½ÉÀüµµ ÀÌ»ó ÃÑÁ¤¸® ±è´ëÈÆ(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 07¿ù 01ÀÏ ´õÄÉÀÌÈ£ÅÚ °Å¹®°íȦ 11:10~11:25 ¾ÏȯÀÚ Ä¡·áÁß ½ÉÀå±â´ÉÀÌ ¶³¾îÁ³´Ù¸é È®ÀÎÇÒ »çÇ×°ú ÀûÀýÇÑ ÇùÁø ½Ã±â Á¤Çý¹®(°æÈñÀÇ´ë)
±³À°½Ã°£ 07¿ù 01ÀÏ ´õÄÉÀÌÈ£ÅÚ °Å¹®°íȦ 11:25~11:40 ¾ÏȯÀÚ ½É³¶ »ïÃâ¾× drainageÀÇ ±âÁØ°ú ¹æ¹ý ¼±Åà ÀÌ´©¸®(Àü³²ÀÇ´ë)
Åä·Ð 07¿ù 01ÀÏ ´õÄÉÀÌÈ£ÅÚ °Å¹®°íȦ 11:40~12:00 Åä·Ð ¹ÚÂù¼®,±èÈñÁØ,¹Ú¼¼ÈÆ,±èÁø¿ø,Á¶Àͼº(°¡Å縯ÀÇ´ë,Áß¾ÓÀÇ´ë,¼º±Õ°üÀÇ´ë,¼¿ïÀÇ´ë,¿¬¼¼ÀÇ´ë)
½Ä»ç 07¿ù 01ÀÏ 12:00~13:00 ½Ä»ç ()
±³À°½Ã°£ 07¿ù 01ÀÏ ´õÄÉÀÌÈ£ÅÚ °Å¹®°íȦ 13:00~13:15 Why should we cooperate? Insights from Unforgettable Cases ½ÉÁö¿µ(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 07¿ù 01ÀÏ ´õÄÉÀÌÈ£ÅÚ °Å¹®°íȦ 13:15~13:35 How can we predict cardiotoxicity induced by anti-cancer treatment before clinical trials? ¹é¸í±â(¢ßÅ׶óÆ彺)
±³À°½Ã°£ 07¿ù 01ÀÏ ´õÄÉÀÌÈ£ÅÚ °Å¹®°íȦ 13:35~13:55 How to Prevent Cardio-toxicity of Chemotherapeutics? A Clinical Pharmacologist ¿ÀÀ缺(¼¿ï´ëÇб³º´¿ø ÀÓ»ó¾à¸®Çаú)
Åä·Ð 07¿ù 01ÀÏ ´õÄÉÀÌÈ£ÅÚ °Å¹®°íȦ 13:55~14:20 Åä·Ð ȲÈñÁ¤,À±Á¾Âù,Á¤¿ì¹é,±è¼ºÀº,¹Ú¼º¹Ì,ÀÓÁÖÇÑ,ÃÖ¼ºÁØ,±èÅÂÀº(°æÈñÀÇ´ë,°¡Å縯ÀÇ´ë,°¡Å縯ÀÇ´ë,ÇѸ²ÀÇ´ë,°í·ÁÀÇ´ë,ÀÎÇÏÀÇ´ë,¿ÂÄÚµå¹ÙÀÌ¿À,°Ç±¹´ëÇб³º´¿ø ÀÓ»ó¾à¸®Çаú)